<DOC>
	<DOC>NCT01260285</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety of vardenafil in cardiac surgery patients.</brief_summary>
	<brief_title>The Safety of Vardenafil in Patients Undergoing Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>undergoing cardiac surgery emergent surgery recent MI in past 7 days prior to surgery ejection fraction &lt; 35% creatinine &gt; 2.0 prior CVA severe COPD recent use of nitrates (within past 48 hours prior to surgery) prior CABG pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>